🇺🇸 FDA
Pipeline program

Dendritic Cell Vaccination

NCT00715832

Phase 2 mab active

Quick answer

Dendritic Cell Vaccination for Breast Cancer is a Phase 2 program (mab) at Quantum Biopharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Quantum Biopharma
Indication
Breast Cancer
Phase
Phase 2
Modality
mab
Status
active

Clinical trials